Authors:
Thomas, RR
Dahut, W
Harold, N
Grem, JL
Monahan, BP
Liang, M
Band, RA
Cottrell, J
Llorens, V
Smith, JA
Corse, W
Arbuck, SG
Wright, J
Chen, AP
Hamilton, JM
Allegra, CJ
Takimoto, CH
Citation: Rr. Thomas et al., A phase I and pharmacologic study of 9-aminocamptothecin administered as a120-h infusion weekly to adult cancer patients, CANC CHEMOT, 48(3), 2001, pp. 215-222
Authors:
Breathnach, OS
Georgiadis, MS
Schuler, BS
Pizzella, P
Llorens, V
Kasturi, V
Steinberg, SM
O'Neil, K
Takimoto, CH
Johnson, BE
Citation: Os. Breathnach et al., Phase II trial of paclitaxel by 96-hour continuous infusion in combinationwith cisplatin for patients with advanced non-small cell lung cancer, CLIN CANC R, 6(7), 2000, pp. 2670-2676
Authors:
Takimoto, CH
Morrison, G
Harold, N
Quinn, M
Monahan, BP
Band, RA
Cottrell, J
Guemei, A
Llorens, V
Hehman, H
Ismail, AS
Flemming, D
Gosky, DM
Hirota, H
Berger, SJ
Berger, NA
Chen, AP
Shapiro, JD
Arbuck, SG
Wright, J
Hamilton, JM
Allegra, CJ
Grem, JL
Citation: Ch. Takimoto et al., Phase I and pharmacologic study of irinotecan administered as a 96-hour infusion weekly to adult cancer patients, J CL ONCOL, 18(3), 2000, pp. 659-667